SEARCH

SEARCH BY CITATION

References

  • 1
    Szmuness W., Hepatocellular carcinoma and the Hepatitis B virus: evidence for a causal association. Prog Med Virol 1978; 24: 4069.
  • 2
    Maupas P, Goudeau A, Coursaget P, Chiron JP, Drucker J, Barin F, Perrin J, et al. Hepatitis B virus infection and primary hepatocellular carcinoma: epidemiological, clinical, and virological studies in Senegal from the per-spective of prevention by active immunization. In: EssexM, TodaroG, Zur HausenH, eds. Viruses in naturally occurring cancer. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1980: 481506.
  • 3
    Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 1981; 2: 11291133.
  • 4
    Blumberg BS. Background and perspective. In: ChisariFV, ed. Advances in hepatitis research. New York: Massen, 1984: 18.
  • 5
    Sureau C, Romet-Lemonne JL, Mullins JI, Essex M. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 1986; 47: 3747.
  • 6
    Yaginuma K, Shirakata Y, Kobayashi M, Koike K. Hepatitis virus (HBV) particles are produced in a cell culture System by transient expression of transfected HBV DNA. Proc Natl Acad Sci U S A 1987; 84: 26782682.
  • 7
    Chang C, Jeng KS, Hu CP, Lo SJ, Su TS, Ting LP, Chou CK, et al. Production of hepatitis B virus in vitro by transient expression of cloned HBV DNA in a hepatoma cell line. EMBO J 1987; 6: 675680.
  • 8
    Han DW, Xu RL, Yeung SCS. Chinese medicines for the prevention and treatment of viral hepatitis. Abst Chin Med 1988; 2: 105134.
  • 9
    Venkateswaran PS, Millman I, Blumberg BS., Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies. Proc Natl Acad Sci U S A 1987; 84: 274278.
  • 10
    Thyagarajan SP, Subramanian S, Thirunalasundari T, Venkateswaran PS, Blumberg BS. Effect of Phyllanthus atnarus on chronic carriers of hepatitis B virus. Lancet 1988; 2: 764766.
  • 11
    Blumberg BS, Millman I, Venkateswaran PS, Thyagarajan SP. Hepatitis B virus and hepatocellular carcinoma-treatment of HBV carries with Phyllanthus amarus. Cancer Detect Prev 1989; 14: 195201.
  • 12
    Wu TS, Liou MJ, Ko FN, Teng CM. Osthole, an antiplatelet aggregation principle from the root of Angelica pubescens. Chin Pharmaceut J 1990; 42: 317322.
  • 13
    Kan WS. In: Pharmaceutical botany. Taiwan: Natl Res Inst Chin Med 1979: 413414.
  • 14
    Kosuge T, Yokota M, Sugiyama K, Yamamoto T, Mure T, Yamazawa H. Studies on bioactive substances in crude drugs used for arthritic diseases in traditional Chinese medicine. II. Isolation and identification of an anti-inflammatory and analgesic principle from the root of Angelica pubescens MAXIM. Chem Pharm Bull 1985; 33: 53515354.
  • 15
    Murayama M, Seto E, Okubo T, Morita I, Dobashi I, Maehara M. Synthetic studies on suberosin and osthol. Chem Pharm Bull 1972; 20: 741746.
  • 16
    Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res 1982; 42: 38583863.
  • 17
    Learned RM, Myers RM, Tjian R: Replication in Monkey Cells of Plasma DNA Containing the Minimal SV40 Origin. In: Rays DS ed. New York: Academic, 1981: 555566.
  • 18
    Cattaneo R, Will H, Darai G, Pfaff E, Schaller H. Detection of an element of the SV40 late promoter in vectors used for expression studies in COS cells. EMBO J 1983; 2: 511514.
  • 19
    Sheu SY, Lo SJ. Preferential ribosomal scanning is involved in the differ-ential synthesis of Hepatitis B viral surface antigens from subgenomic transcripts. Virology 1992; 188: 353357.
  • 20
    Tietz NW. Fundamentals of clinical chemistry. Philadelphia: Saunders, 1976: 674.
  • 21
    Junker M, Galle P, Schaller H. Expression and replication of the hepatitis B virus genome under a foreign promoter control. Nucleic Acids Res 1987; 15: 1011710132.
  • 22
    Chomczinski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate phenol Chloroform extraction. Anal Biochem 1987; 162: 156159.
  • 23
    Lee SC, Shew JY, Chang ACH. Monoclonal antibodies to hepatitis B sur-face antigen (HBsAg) produced by somatic cell hybrids. J Formos Med Assoc 1984; 83: 142148.
  • 24
    Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680685.
  • 25
    Lee TH, Coligan JE, Homma T, McLane MF, Tachibana N, Essex M., Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection. Proc Natl Acad Sci USA 1984; 81: 38563860.
  • 26
    Hepadnaviruses. In: MasonWS, SeegerC, eds. Berlin: Springer, 1991: 6184.
  • 27
    Patzer EJ, Nakamura GR, Simonsen CG, Levinson AD, Brands R. Intracel-lular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum. J Virol 1986; 58: 884892.
  • 28
    Mishiro S, Imai M, Takahashi K, Machida A, Gotanda T, Miyakawa Y, Mayumi M. A 49,000-dalton polypeptide bearing all antigenic determi-nants and föll immunogenicity of 22-nm hepatitis B surface antigen particles. J Immunol 1980; 124: 15891593.
  • 29
    Tiollais P, Charnay P, Vyas GN. Biology of hepatitis B virus. Science 1981; 213: 406411.
  • 30
    Lee B, Luo W, Suzuki S, Robins MJ, Tyrrell DLJ. In vitro and in vivo comparison of the abilities of purine and pyrimidine 2′,3′-dideoxynucleo-sides to inhibit duck hepadnavirus. Antimicrob Agents Chemother 1989; 33: 336339.
  • 31
    Price PM, Banerjee R, Acs G. Inhibition of the replication of hepatitis B virus by the carbocyclic analogue of 2′-deoxyguanosine. Proc Natl Acad Sci U S A 1989; 86: 85418544.
  • 32
    Doong SL, Tsai CH, Schinazi RF, Liotta DC, Cheng YC. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci U S A 1991; 88: 84958499.
  • 33
    Block TM, Lu X, Platt FM, Foster GR, Gerlich WH, Blumberg BS, Dwek RA. Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proc Natl Acad Sci U S A 1994; 91: 22352239.